Kastrati, Adnan, A. Byrne, Robert, Mehilli, Julinda, Laugwitz, Karl-Ludwig, Schunkert, Heribert, Fischer, Marcus, Bernlochner, Isabell, Ibrahim, Tareq, Morath, Tanja, Kufner, Sebastian, Wöhrle, Jochen, Jacobshagen, Claudius, Zrenner, Bernhard, Maeng, Michael, Seyfarth, Melchior, Tölg, Ralph, Adriaenssens, Tom, Han, Yaling, Neumann, Franz-Josef, Berg, Jurrien M. ten, Wolk, Annabelle, Giacoppo, Daniele, Colleran, Roisin, Lena Lahmann, Anna, Emmer, Roberto, Mayer, Katharina, Lohaus, Raphaela, Michel, Jonathan, Harada, Yukinori and Schulz-Schüpke, Stefanie (2017) Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. Thrombosis and Haemostasis 117 (10), pp. 1989-1999.
Full text not available from this repository.
Other URL: http://doi.org/10.1160/TH17-02-0101
Abstract
The DAPT score is a recently-proposed decision tool for guiding optimal duration of dual antiplatelet therapy (DAPT). It showed modest accuracy in prior derivation and validation cohorts of patients with >= 12 months DAPT. This study was aimed to evaluate the validity of the DAPT score in a cohort of patients with 6 or 12 months DAPT after implantation of predominantly second-generation ...
Export bibliographical data
| Item type: | Article | ||||
|---|---|---|---|---|---|
| Date: | 2017 | ||||
| Institutions: | Medicine > Lehrstuhl für Innere Medizin II | ||||
| Identification Number: |
| ||||
| Keywords: | DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; GUIDELINE FOCUSED UPDATE; PLACEBO-CONTROLLED TRIAL; HAS-BLED SCORE; ARTERY-DISEASE; NETWORK METAANALYSIS; DOUBLE-BLIND; RISK SCORES; ISAR-SAFE; Dual antiplatelet therapy; DAPT score; second-generation drug-eluting stent; stent thrombosis | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 39730 |
Altmetric